asp3772
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 24, 2019 (NCT03803202)
Timeline
Indications
Mechanism of action
- Streptococcus pneumoniaeImmunity, active
Streptococcus pneumoniae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05412030 | Phase 2 | Jun 16, 2022 | Affinivax |
| NCT04525599 | Phase 1 | Sep 22, 2020 | Affinivax, Astellas |
| NCT04265911 | Phase 1 | Feb 29, 2020 | Affinivax, Astellas |
| NCT03803202 | Phase 1/Phase 2 (Phase 2) | Jan 24, 2019 | Affinivax, Astellas |
Showing 4 of 4 trials
Page 1 / 1